Fibromyalgia nerve stimulators get an easier path to market

The US health regulators just made it easier for a specific type of nerve stimulator to treat fibromyalgia. This means manufacturers can bring these devices to patients with less regulatory burden.

Getting a new medical device approved by US health regulators can be a long, expensive process. This rule change specifically lowers that bar for transcutaneous electrical nerve stimulators used to treat fibromyalgia, making it faster and cheaper for companies to sell them. The goal is to give patients more options for a chronic condition.